Mode
Text Size
Log in / Sign up
N/A Completed N=14 Treatment

Effects of Reparel™ Knee Sleeve on Knee Osteoarthritis

Source: ClinicalTrials.gov NCT04743921 ↗
Enrolled (actual)
14
Serious AEs
0.0%
Results posted
May 2024
Primary outcomePrimary: University of California, Los Angeles (UCLA) Activity Score — 5.4 score on a scale

Summary

The goals of treating knee osteoarthritis (OA) is to improve or maintain quality of life, mobility and function, pain relief, and improve inflammation. The different treatment options for knee OA have been extensively studied and implemented, but the optimum treatment is still undecided. There is a belief that anti-inflammatory sleeve technology may be beneficial in treating knee OA. The purpose of this study is to determine the clinical effects of Reparel™ knee sleeve regarding mobility, functionality, and pain outcomes in managing knee OA.

Outcome Measures

OutcomeResultp-value
PRIMARY
University of California, Los Angeles (UCLA) Activity Score
5.4
PRIMARY
Lysholm Score
75.0
PRIMARY
Oxford Knee Score (OKS)
38.2
PRIMARY
Knee Injury and Osteoarthritis Outcome Score Pain (KOOS-P)
72.9
PRIMARY
Single Assessment Numeric Evaluation (SANE)
72.0
PRIMARY
Visual Analog Scale (VAS)
3.0
PRIMARY
Knee Injury and Osteoarthritis Outcome Score Symptoms (KOOS-Sy)
75.6
PRIMARY
Knee Injury and Osteoarthritis Outcome Score Activities of Daily Living (KOOS-ADL)
81.37
PRIMARY
Knee Injury and Osteoarthritis Outcome Score Quality of Life (KOOS-QOL)
59.9
PRIMARY
Knee Injury and Osteoarthritis Outcome Score Sports and Recreation (KOOS-Sp)
47.5

Eligibility Criteria

Inclusion Criteria

  • osteoarthritis visible on knee radiograph
  • patient opting for non-surgical treatment
  • no corticosteroid knee injection for 90 days prior to consent
  • no corticosteroid knee injection for 90 days following consent

Exclusion Criteria

  • bilateral symptomatic knee osteoarthritis
  • prior surgery on the knee of interest
  • hardware present on the knee of interest
  • gross instability detected on physical exam
  • malignancy in the knee of question
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04743921). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search